Literature DB >> 17483716

Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature.

Maria Moschovi1, Vassiliki Touliatou, Touliatou Vassiliki, Anna Papadopoulou, Papadopoulou Anna, Maria-Alexandra Mayakou, Mayakou Maria-Alexandra, Polyxeni Nikolaidou-Karpathiou, Nikolaidou-Karpathiou Polyxeni, Sophia Kitsiou-Tzeli, Kitsiou-Tzeli Sophia.   

Abstract

An increased risk of different types of malignancy has been reported in patients with Noonan syndrome (NS). We describe a patient with short stature, dysmorphic features, developmental delay, and congenital cardiomyopathy. At 5 years old, he presented with abdominal pain, constipation, and evaluation with ultrasound and computed tomography scan demonstrated the presence of an abdominal mass. Total resection of the mass and consequent histology revealed an embryonal rhabdomyosarcoma. Rhabdomyosarcoma is a rare tumor in NS patients and to the best of our knowledge only 2 cases have been reported so far. The presentation underlines the importance of frequent follow-up of patients with NS, since the incidence of malignancy is low but existing.

Entities:  

Mesh:

Year:  2007        PMID: 17483716     DOI: 10.1097/MPH.0b013e31805d8f57

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  14 in total

1.  Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.

Authors:  Neerav Shukla; Nabahet Ameur; Ismail Yilmaz; Khedoudja Nafa; Chyau-Yueh Lau; Angela Marchetti; Laetitia Borsu; Frederic G Barr; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

Review 2.  Developmental origins of fusion-negative rhabdomyosarcomas.

Authors:  Ken Kikuchi; Brian P Rubin; Charles Keller
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

3.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

4.  Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.

Authors:  José M Rojas; José Luis Oliva; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

5.  Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype.

Authors:  S Ognjanovic; S E Carozza; E J Chow; E E Fox; S Horel; C C McLaughlin; B A Mueller; S Puumala; P Reynolds; J Von Behren; L Spector
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

6.  An unusually large spindle cell sarcoma of the tongue in a male child.

Authors:  A E Abdulai; I K Nuamah; D Avogo; R K Gyasi; L A Renner
Journal:  Ghana Med J       Date:  2013-12

7.  Tumor development in three patients with Noonan syndrome.

Authors:  Helen Fryssira; George Leventopoulos; Stavroula Psoni; Sophia Kitsiou-Tzeli; Nikolaos Stavrianeas; Emmanuel Kanavakis
Journal:  Eur J Pediatr       Date:  2007-12-05       Impact factor: 3.183

8.  Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.

Authors:  Andreas von Deimling; Christian Koelsche; Felix K F Kommoss; Damian Stichel; Jaume Mora; Manel Esteller; David T W Jones; Stefan M Pfister; Eva Brack; Marco Wachtel; Peter Karl Bode; Hans-Peter Sinn; Dietmar Schmidt; Thomas Mentzel; Friedrich Kommoss; Felix Sahm
Journal:  Mod Pathol       Date:  2021-04-12       Impact factor: 7.842

9.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

Authors:  Marjolijn C J Jongmans; Ineke van der Burgt; Peter M Hoogerbrugge; Kees Noordam; Helger G Yntema; Willy M Nillesen; Roland P Kuiper; Marjolijn J L Ligtenberg; Ad Geurts van Kessel; J Han J M van Krieken; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.